Information  X 
Enter a valid email address

CVS Group plc (CVSG)

  Print      Mail a friend       Annual reports

Monday 30 September, 2019

CVS Group plc

Exercise of Options and Total Voting Rights

RNS Number : 2104O
CVS Group plc
30 September 2019

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights


CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, confirms that it has issued a total of 509 new ordinary shares of 0.2 pence each ("Ordinary Shares") during September, as a result of the exercise of options by certain employees under the Company's Save As You Earn (SAYE) 2015/2018 scheme (the "SAYE Shares").

The SAYE Shares rank pari passu with all existing Ordinary Shares and admission has been satisfied via the Company's block listing, application for which was announced on 19 December 2018.

Following the above new issuance, the Company has a total issued share capital at the date of this announcement of 70,653,893 Ordinary Shares each carrying one voting right.

The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,653,893. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.



CVS Group Plc                                                         Tel: 01379 644288

Simon Innes, Chief Executive

Richard Fairman, Finance Director                  


N+1 Singer (Nominated Adviser & Broker)    Tel: 0207 496 3000

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t